Sumitomo Dainippon Pharma Co. Ltd

Headquarters: Osaka, Japan

Employees: 6,822

CEO: Mr. Hiroshi Nomura

show_chart JPX: 4506 -1.48%

Market Cap

¥263.84 Billion

JPY as of July 1, 2023

US$1.83 Billion

history Market Cap History

Sumitomo Dainippon Pharma Co. Ltd market capitalization over time

Evolution of Sumitomo Dainippon Pharma Co. Ltd market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

history Market Cap History of Sumitomo Dainippon Pharma Co. Ltd

Detailed Description

Sumitomo Dainippon Pharma Co., Ltd. manufactures and sells pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally. The company offers pharmaceutical products, such as therapeutic agents for Parkinson's disease, depression, type 2 diabetes, systemic fungal infection, hypertension, pruritus, chronic obstructive pulmonary disease, angina pectoris, and arrhythmia. It also provides products for atypical antipsychotic, antiepileptic, carbapenem antibiotic, and gastrointestinal; and Anderson-Fabry disease drugs. In addition, the company offers food ingredients and additives, such as polysaccharides, as well as seasonings, such as soups or bouillons; and chemical product materials, which include pharmaceutical excipients, personal care products, coatings and industrial materials, and electronic materials. Further, it provides veterinary medicines for companion animals, such as dogs and cats; and livestock comprising cattle, swine, poultry, horses, and aquacultured fish. Sumitomo Dainippon Pharma Co., Ltd. has partnerships with Healios K.K.; Keio University; RIKEN; the Center for iPS Cell Research and Application; Kyoto University; and Aikomi Co., Ltd., as well as a joint development agreement with SanBio Company Limited; and collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. It also has a strategic alliance with Roivant Sciences Ltd. The company was formerly known as Dainippon Sumitomo Pharma Co., Ltd. and changed its name to Sumitomo Dainippon Pharma Co., Ltd. in June 2014. The company was founded in 1897 and is headquartered in Osaka, Japan. Sumitomo Dainippon Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited.

Stocks & Indices

Sumitomo Dainippon Pharma Co. Ltd has the following listings and related stock indices.

Stock: JPX: 4506

Stock: FSX: DPM




6-8 Doshomachi 2-chome


Osaka, 541-0045


Phone: 81 6 6203 5321

Fax: 81 6 6202 6028